Avantor Inc
NYSE:AVTR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Avantor Inc
Free Cash Flow
Avantor Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Avantor Inc
NYSE:AVTR
|
Free Cash Flow
$495m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Free Cash Flow
$6.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
10%
|
|
|
Danaher Corp
NYSE:DHR
|
Free Cash Flow
$5.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
|
Waters Corp
NYSE:WAT
|
Free Cash Flow
$539.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
1%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Free Cash Flow
$993m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Free Cash Flow
$2.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
|
Avantor Inc
Glance View
Avantor Inc. is a unique force in the world of life sciences, a field where precision and reliability are as vital as oxygen to human existence. This Pennsylvania-based corporation manages to weave a complex tapestry of innovation and efficiency in its mission to support scientific advancement across the globe. Avantor operates within a diverse landscape, offering a vast array of products that cater to a wide spectrum of industries, including biotechnology, pharmaceutical, healthcare, industrial, and applied materials. At its core, the company functions as a crucial provider of high-purity materials, customized solutions, and highly specialized services that researchers, scientists, and professionals rely on daily to push the boundaries of what's possible. Avantor makes its money through its strategic integration of manufacturing high-quality laboratory and production materials with a comprehensive distribution network. The company boasts a robust catalog of over six million products, including chemicals, reagents, and other essential laboratory supplies. By leveraging its expansive reach and deep-rooted presence in over 30 countries, Avantor efficiently links product innovation with customer needs. Their operations are not merely transactional but are deeply embedded with a service-oriented approach, ensuring that they not only meet the diverse needs of their clients but also continually innovate to help advance scientific breakthroughs. Profitability stems from both the direct sale of products and long-term service agreements, which foster enduring partnerships and create a strong revenue stream, reinforcing Avantor's stature as a pillar in the life sciences sector.
See Also
What is Avantor Inc's Free Cash Flow?
Free Cash Flow
495m
USD
Based on the financial report for Dec 31, 2025, Avantor Inc's Free Cash Flow amounts to 495m USD.
What is Avantor Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-11%
Over the last year, the Free Cash Flow growth was -28%. The average annual Free Cash Flow growth rates for Avantor Inc have been -11% over the past three years , -11% over the past five years .